Literature DB >> 33708050

Comparison of Total Immunoglobulin G in Ante- and Postmortem Blood Samples from Tissue Donors.

Gudrun Larscheid1, Tino Schulz2, Hermann Herbst1, Tina Trögel1, Sascha Eulert3, Axel Pruß2, Jan Schroeter2.   

Abstract

BACKGROUND: A serology testing for infectious diseases (HIV, hepatitis B and C, syphilis) is mandatory in tissue donors. In many donors postmortem blood is the only sample available. Even though serological tests and nucleic acid amplification tests (NAT) used are validated for postmortem blood, a characterization of those blood samples is not yet established. We therefore investigated the total immunoglobulin G (IgG) content in postmortem blood of tissue donors and compared it to a corresponding antemortem blood sample.
METHODS: Ante- and postmortem blood samples were obtained from 100 consecutive tissue donors. The total IgG of all samples was measured using an immune-turbidometric test on the AU 480 Chemistry Analyzer (Beckman Coulter).
RESULTS: The mean total IgG concentration of antemortem blood samples from all 100 donors was 8.9 g/L ± 3.7 g/L (median 8.9 g/L, range 1.5 to 23.8 g/L). In 80 donors the IgG concentration in the antemortem blood sample was within the normal range with values ≥6 g/L (mean 10.0 g/L ± 3.3 g/L, median 9.3 g/L,). The total IgG concentration of the postmortem blood samples was lower with 7.2 g/L ± 3.2 g/L (median 6.7 g/L, range 0.6 to 18.2 g/L). The difference between the values of the antemortem and postmortem blood samples was 1.7 g/L ± 2.6 g/L (16.3%) (median 1.6 g/L, range -7.7 to 10.1 g/L). In 36 donors this difference was less than 10%, in 23 it was between 10 and 25%, in 33 between 26 and 50%, and in 8 over 50%. In 57 donors the total IgG in the postmortem blood sample was within the normal range with ≥6 g/L, in 53 of them also the value of the antemortem blood sample was within the normal range. No correlation for total IgG was found regarding the donor characteristics (age, sex, disease) and the sample characteristics (hemolysis, postmortem time).
CONCLUSION: Total IgG values in antemortem samples were below the lower limit of 6 g/L in 20% of the cases. Total IgG was significantly lower in the postmortem samples compared to the antemortem samples, while 57% were still above the lower limit. No correlation with the postmortem time could be found. This lowered IgG levels should be payed attention to when using postmortem blood for infectious serology testing. Additional NAT testing should be considered.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Donor screening; Immunoglobulin; Postmortem blood; Tissue bank; Tissue donation

Year:  2021        PMID: 33708050      PMCID: PMC7923840          DOI: 10.1159/000513662

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  14 in total

1.  Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples.

Authors:  Knut Gubbe; Yvonne Scharnagl; Steffi Grosch; Torsten Tonn; Michael Schmidt; Kai M Hourfar; Andreas Karl; Erhard Seifried; Ina Wilkemeyer; Ulrich Kalus
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

2.  Nucleic acid testing and tissue safety: an eye bank's five-year review of HIV and hepatitis testing for donor corneas.

Authors:  Ellen Heck; Allen Brown; H Dwight Cavanagh
Journal:  Cornea       Date:  2013-04       Impact factor: 2.651

3.  Serum immunoglobulin levels in healthy children and adults.

Authors:  J W Stoop; B J Zegers; P C Sander; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Trends in Corneal Transplantation from 2001 to 2016 in Germany: A Report of the DOG-Section Cornea and its Keratoplasty Registry.

Authors:  Elias Flockerzi; Philip Maier; Daniel Böhringer; Helga Reinshagen; Friedrich Kruse; Claus Cursiefen; Thomas Reinhard; Gerd Geerling; Necip Torun; Berthold Seitz
Journal:  Am J Ophthalmol       Date:  2018-02-02       Impact factor: 5.258

5.  Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor.

Authors:  Barna D Tugwell; Priti R Patel; Ian T Williams; Katrina Hedberg; Feng Chai; Omana V Nainan; Ann R Thomas; Judith E Woll; Beth P Bell; Paul R Cieslak
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

6.  A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death.

Authors:  Carolin Edler; Birgit Wulff; Ann-Sophie Schröder; Ina Wilkemeyer; Susanne Polywka; Thomas Meyer; Ulrich Kalus; Axel Pruss
Journal:  J Med Microbiol       Date:  2011-03-24       Impact factor: 2.472

Review 7.  Tissue donation and virus safety: more nucleic acid amplification testing is needed.

Authors:  A Pruss; G Caspari; D H Krüger; J Blümel; C M Nübling; L Gürtler; W H Gerlich
Journal:  Transpl Infect Dis       Date:  2010-10       Impact factor: 2.228

8.  Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.

Authors:  S Dietz; C Lautenschläger; U Müller-Werdan; G Pilz; P Fraunberger; M Päsler; H Ebelt; A K Walli; K Werdan; S Nuding
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-27       Impact factor: 0.840

Review 9.  [Procedural guidelines. Good tissue practice for cornea banks].

Authors:  J Schroeter; P Maier; J Bednarz; K Blüthner; M Quenzel; A Pruss; T Reinhard
Journal:  Ophthalmologe       Date:  2009-03       Impact factor: 1.059

10.  Global Survey of Corneal Transplantation and Eye Banking.

Authors:  Philippe Gain; Rémy Jullienne; Zhiguo He; Mansour Aldossary; Sophie Acquart; Fabrice Cognasse; Gilles Thuret
Journal:  JAMA Ophthalmol       Date:  2016-02       Impact factor: 7.389

View more
  2 in total

1.  Palaeoserology - teeth put into ancient plagues and pandemics.

Authors:  Kai Dallmeier
Journal:  Microb Biotechnol       Date:  2022-04-27       Impact factor: 6.575

2.  First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.

Authors:  Rohan Ameratunga; See-Tarn Woon; Mary N Sheppard; Jack Garland; Benjamin Ondruschka; Christopher X Wong; Ralph A H Stewart; Michael Tatley; Simon R Stables; Rexson D Tse
Journal:  J Clin Immunol       Date:  2022-01-03       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.